Christine Garnier

Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ

Qualyst Transporter Solutions LLC provides hepatic drug transporter products and contract research services utilizing the patented B-CLEAR technology. The company was founded by Kenneth R. Brouwer, Gary M. Pollack and Dhiren R. Thakker in 2001 and is headquartered Durham, NC.

Pharmaleads SA specializes in the detection, inhibition and modulation of proteases involved in human diseases. It designs and develops analgesic drugs with the aim to revolutionize the treatment of severe pain, with no side effects. The firm's products include high fluorescence substrates for proteases, substrates for BoNT quantification, and EzyBot, a field kit for botulinum toxin detection. The company was founded in 2000 by Bernard Roques and Marie-Claude Fournié-Zaluski and is headquartered in Paris, France.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

iXBlue SAS manufactures navigation systems using high-spec fiber-optic gyroscopes. The firm offers surface gyrocompasses, photonic components and modules, motion simulators, stabilized platforms, testing and calibration tables, optical fibers and modulators, surface and unmanned underwater vehicle navigators, and space sensors. The company was founded on September 27, 2000 and is headquartered in Saint-Germain-en-Laye, France.

Part of UCB SA, UCB Pharma SA (France) specializes in allergic and respiratory diseases and disorders. The company is based in Nanterre, France.

Edmond de Rothschild (Suisse) SA (Private Banking) (Rothschild-PB) is the private banking division of Edmond de Rothschild (Suisse) SA (SW: RLD) in Switzerland. Established in 1924, the firm is located in Geneva and provides private banking, investment advisory and asset management services to high-net worth individuals. Rothschild-PB manages a diverse range of funds. They manage their Luxembourg-domiciled umbrella product PriFund cooperatively with the group's affiliate La Compagnie Benjamin de Rothschild SA, in particular the quantitative compartments.

National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD.

Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA.

VAXON Biotech SA develops therapeutic vaccines for the treatment of cancers. It offers treatment for lung, gastric, prostate, breast, renal, liver, and colorectal cancers, using its proprietary technology of optimized cryptic peptides. The firm also provides research and development services. The company was founded by Konstantinos Kosmatopoulos in 2004 and is headquartered in Paris, France.

Convergent Capital SA (CC) is a venture capital investment firm established in 2001 and located west of Paris. CC manages the Convergent Technologies FCPR fund. Their international clientele comprises business angels, entrepreneurs, and institutions including public entities and financial institutions.

iXCore deals with marine, aeronautics, and fund industries. It offers in maritime, land and space industry, biotechnology, and investment. The company was founded on September 21, 2001 and is headquartered in Marly-le-Roi, IF.

Part of Pfizer Inc., Wyeth Farma SA is a Spanish company that manufactures and supplies drugs. The company is based in San Sebastian de los Reyes, Spain.

BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium.

Founded in 1995, AEC Partners is a private equity firm located in New York City.

Invus SAS (Investment Management) (Invus-IM) is the investment management division of Invus SAS, a private equity firm headquartered in Paris, France. The firm is owned by The Invus Group LLC in the US. Invus-IM makes equity investments in public companies.

Edmond de Rothschild (Suisse) SA (Investment Management) (RLD-IM) is the investment management division of full-service bank Edmond de Rothschild (Suisse) SA (SW: RLD) in Switzerland. Founded in 1969, the firm is headquartered in Geneva and specializes in providing wealth management services for private and institutional clients.

Part of Pfizer Inc., Pharmacia Nostrum SA leases real estate properties. The company is based in Madrid, Spain.

Part of Pfizer Inc., Vinci Farma SA is a wholesaler of pharmaceutical goods. The company is based in Madrid, Spain.

Part of Pfizer Inc., BINESA 2002 SL is a Spanish company that retails pharmaceutical products. The company is based in Madrid, Spain.

Part of Zoetis, Inc., Zoetis Spain SL develops, manufactures, and wholesales animal health medicines. The company is based in Madrid, Spain.

Part of Pfizer Inc., Hospira Invicta SA is a Spanish company that wholesales pharmaceutical products. The company is based in Madrid, Spain.

ATANIS Biotech AG is a company based in Oberkirch, Germany that provides a functional allergy diagnostic screening test. The German company's mission is to revolutionize the way allergies are diagnosed and improve treatment success. The company is driven by scientific excellence and provide a proprietary mast cell line that functions as an ex vivo alternative to in vivo testing. Noemi Bachmeier-Zbären, Jean-Pierre Kinet has been the CEOs since 2021. The company was founded in 2021 by Alexander Eggel, Thomas Kaufmann, Noemi Bachmeier-Zbären, Jean-Pierre Kinet.

Theravectys SAS provides biotechnology research services. It is working on the development of a therapeutic vaccine against HIV. The company was founded on May 17, 2005 and is headquartered in Paris, France.